In this activity, Drs Ostrosky-Zeichner, Peter Pappas, Jose Vazquez, and Jennifer Rodriguez-Cuellar have presented strategies to make a difference in the management of invasive candidiasis. The cases discussed include Candida auris, management of allogeneic hematopoietic stem cell transplantation, and an intra-abdominal surgical case.
Release Date: September 12, 2023
Expiration Date: September 11, 2024
Estimated Time to Complete the Activity: 1.5 hrs
Media: Interactive, text-based activity
Upon completing this activity, the participant should be better able to:
This initiative is directed to infectious diseases physicians, critical care physicians, hospitalists, surgeons, pathologists/clinical microbiologists, hematologists/oncologists, pharmacists, pediatric infectious disease specialists, transplant specialists, and other health care providers responsible for the management of invasive candidiasis.
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE); Terranova Medica, LLC; and the Mycoses Study Group Education and Research Consortium (MSGERC). PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
PACE designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PACE designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number – JA4008073-9999-23-184-H01-P
Type of Activity: Knowledge
PACE requires planners, faculty, and others who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following financial relationships or relationships to products or devices they have with ineligible companies:
Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA, FECMM, CMQ
RESEARCH SUPPORT: Astellas, Gilead, Pfizer, Pulmocide, Scynexis , T2Biosystems
CONSULTANT: Cidara, F2G, GSK, Pfizer, Viractor, Melinta
Jennifer Cuellar-Rodriguez, MD
Has no relevant financial relationship(s) with ineligible companies to disclose
Peter Pappas, MD, FACP
RESEARCH SUPPORT: Melinta, Scynexis
CONSULTANT: F2G, Matinas
Jose Vazquez, MD, FACP, FIDSA
RESEARCH SUPPORT: Scynexis
CONSULTANT: Cidara, F2G
Lisa A. Tushla, PhD, H(ASCP) of Terranova Medica, LLC discloses research support from Bristol Myers Squibb and Novartis. Ava Duffy has no relevant financial relationship(s) to disclose with ineligible companies. The MSGERC and PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
Participation in this self-study activity should be completed in approximately 1.5 hour(s). To successfully complete this activity and receive CE credit, learners must follow these steps during the period from September 12, 2023 through September 11, 2024:
If you wish to receive acknowledgment for completing this activity, please follow the steps below:
You must receive a test score of at least 75% and respond to all evaluation questions to receive a certificate.
For Pharmacists: Upon successfully completing the post-assessment, your credit will be submitted to CPE Monitor. Please check your NABP account within thirty (30) days to make sure the credit has posted.
Internet
To participate, you will need access to a computer (either MAC or PC), tablet, or smart phone, with a Chrome (version 22.0.1229.94 or greater) web browser, Firefox (version 3.6 or greater) web browser or an Internet Explorer (version 8.0 or greater) web browser, JavaScript enabled, connected to the Internet (high speed connection preferred).
Terranova Medica, LLC, and PACE are committed to protecting the privacy of those who choose to participate in activities on funguscme.org. This information below describes our security policies for safeguarding personal information as well as the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of personal information
Terranova Medica, LLC, and PACE do not transfer, sell, or share personal information with outside parties. We will not disclose the information unless required in a legal proceeding.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration (FDA). The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There is no charge for this activity.
Jointly provided by PACE; Terranova Medica, LLC; and the Mycoses Study Group Education & Research Consortium.
This activity is supported by an independent educational grant from Melinta Therapeutics.
For further information, contact Tom Davis by telephone (877-276-4523), or by email (tdavis@terranovamedica.com).
Copyright © 2023 PACE, MSGERC, and Terranova Medica.
